Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have protein phosphatase 1 binding activity and ubiquitin protein ligase activity. Predicted to be involved in several processes, including negative regulation of phosphatase activity; protein autoubiquitination; and regulation of cellular protein metabolic process. Predicted to localize to nucleoplasm. Is expressed in central nervous system; dorsal root ganglion; and neural retina. Used to study autism spectrum disorder. Orthologous to human SH3RF2 (SH3 domain containing ring finger 2).